A new method is developed to track dormant HIV-infected cells. This breakthrough may lead to new treatments that eliminate ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow ...

Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...

Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...

Gilead Sciences, Inc. (NASDAQ:GILD) presented data from its HIV treatment portfolio and pipeline at the Conference on ...

When volunteers launched Pittsburgh Aids Task Force in 1985, they didn’t expect the organization would be operating 40 years later.

Camp Dreamcatcher in Chester County, launched at the height of ‘90s stigma around HIV, has served thousands of children ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of late-breaking data and multiple oral presentations from its innovative HIV treatment portfolio and pipeline at the Conference ...

One of the hot topics at this year's Conference on Retroviruses and Opportunistic Infections will be long COVID: potential ...

Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025IMC-M113V was well ...

Meets Primary Endpoint in Phase 2 Study and Gains Breakthrough Therapy Designation – – Late-Breaker Oral Presentation of Phase 2 Results from the First HIV Cure Clinical Trial Conducted in ...